Anika Therapeutics Inc (ANIK) Live Share Price, Invest From India

Anika Therapeutics Inc Stock Performance

as on January 21, 2026 at 2:29 am IST

Day's Low
Day's High
$9.24
Day's Price Range
$9.54
$9.46
2.33%
Downside
0.85%
Upside
52 Week's Low
52 Week's High
$7.87
52-Week Price Range
$18.37
$9.46
16.81%
Downside
94.19%
Upside

Anika Therapeutics Inc share price movements today

Previous Close: $9.31
Open: $9.31
Volume: 442.9K
Day's Low - High: $9.24 - $9.54
52 Week Low - High: $7.87 - $18.37

Anika Therapeutics Inc Historical Returns

1 Month Return: -1.15 %
3 Month Return: -3.27 %
1 Year Return: -42.67 %
3 Year Return: -69.42 %
5 Year Return: -75.89 %

Anika Therapeutics Inc Stock Fundamentals & Key Indicators

Check Anika Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$136.4M

EPS (TTM)

-0.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.51%

PE Ratio (TTM)

-5.11

Industry PE ratio

-1.6651931330472103

PEG Ratio

3.5808

EBITDA

-3.7M

Revenue (TTM)

112.8M

Profit Margin

-29.29%

Return On Equity TTM

-8.73%

Anika Therapeutics Inc Stock Valuation

Track how Anika Therapeutics Inc P/E has moved over time to understand its valuation trends.

Anika Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-75.86x)

March 31, 2021

Today (-5.11x)

January 21, 2026

Industry (-1.67x)

January 21, 2026

Highest (138.02x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -5.11x

Anika Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anika Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Anika Therapeutics Inc	BUY	$136.4M	-75.89%	-5.11	-29.29%
United Therapeutics Corporation	BUY	$21.2B	NA	17.76	40.65%
Haleon Plc Spon Ads	BUY	$43.8B	NA	21.84	13.81%
Viatris Inc.	HOLD	$14.8B	-26.86%	-21.95	-26.13%
Zoetis Inc.	BUY	$55.2B	-25.06%	20.95	28.21%

Stock Returns calculator for Anika Therapeutics Inc Stock including INR - Dollar returns

The Anika Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Anika Therapeutics Inc investment value today

Current value as on today

₹63,665

Returns

₹36,335

(-36.33%)

Returns from Anika Therapeutics Inc Stock

₹42,667 (-42.67%)

Dollar Returns*

₹6,332 (+6.33%)

Analyst Recommendation on Anika Therapeutics Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Anika Therapeutics Inc. Average target price of $16

Anika Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Anika Therapeutics Inc.

What analysts predicted

40.87%UPSIDE

Target Price

$16

Current Price

$9.46

Analyzed by

9 Analysts

Target

$16.00

Anika Therapeutics Inc target price $16, a slight upside of 40.87% compared to current price of $9.46. According to 9 analysts rating.

Anika Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Anika Therapeutics Inc Stock has increased by 120% in the last 30 days, reflecting an upward trend in search activity.

Time period: December 22, 2025 to January 21, 2026

Change:120% versus previous 30 day period

Anika Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	44	41	42	40	30	38	-1	26	28	27
Gross Profit	28	24	26	24	20	1	22	14	14	15
Operating Income	-3	-7	-63	-5	-1	-28	27	-4	-4	-3
EBITDA	0	-4	1	-1	0	-25	26	-2	-2	0
Interest Expense	0	-	1	0	-	-	-	0	0	1
Depreciation	3	3	3	2	2	2	1	1	1	1
Income Before Tax	-3	-7	-63	-4	-1	-27	28	-3	-3	-2
Income Tax Expense	0	0	0	0	1	2	2	0	0	0
Net Income	-2	-6	-63	-4	0	-29	-21	-4	-3	-2
Net Profit Margin	-6.19%	-15.86%	-146.61%	-11.14%	-0.29%	-77.20%	1694.96%	-18.62%	-14.07%	-8.37%

Anika Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	92	103	113	105	114	130	147	156	120	119
Gross Profit	71	79	86	74	85	69	82	93	82	75
Operating Income	48	50	45	21	34	-28	2	-19	0	-5
EBITDA	51	54	50	27	40	-1	-4	-4	15	3
Interest Expense	0	0	0	1	7	0	0	0	2	2
Depreciation	-	-	4	5	5	13	14	14	14	8
Income Before Tax	48	50	46	23	36	-28	2	-18	3	-2
Income Tax Expense	17	18	14	4	8	-4	-1	-3	6	6
Net Income	30	32	31	18	27	-23	4	-14	-82	-56
Net Profit Margin	33.07%	31.48%	28.05%	17.74%	23.73%	-18.38%	2.80%	-9.51%	-68.44%	-47.02%

Anika Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-6	-63	-1	0	-29	-21	-4	-3	-2
Operating Cash Flow	6	3	0	-1	5	1	0	0	6
Investing Cash Flow	0	-1	-1	-3	-1	-1	1	0	-1
Financing Cash Flow	0	0	-2	-1	-3	-5	-5	0	0
Change in Cash	5	2	0	-5	0	-5	-3	0	4

Anika Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	32	31	18	27	-23	4	-14	-82	-56
Operating Cash Flow	23	40	34	37	13	8	4	-1	5
Investing Cash Flow	-6	-12	-50	39	-71	-3	-7	-5	-8
Financing Cash Flow	-23	0	-28	-8	-3	-6	-4	-6	-12
Change in Cash	-6	28	-44	68	-61	-1	-8	-13	-15

Global Institutional Holdings in Anika Therapeutics Inc

Funds	Holdings
Jacobs Levy Equity Management, Inc.	0.83%
Morgan Stanley - Brokerage Accounts	0.75%
Opaleye Management Inc	4.08%
BOOTHBAY FUND MANAGEMENT, LLC	3.67%
Renaissance Technologies Corp	3.66%

See all

Insights on Anika Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, -29.91M → -2.32M (in $), with an average increase of 119.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 27.2% return, outperforming this stock by 69.9%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 78.9% return, outperforming this stock by 148.3%
NEGATIVE IMPACT
Price Dip
In the last 1 year, ANIK stock has moved down by -42.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 28.21M → 27.81M (in $), with an average decrease of 1.4% per quarter

About Anika Therapeutics Inc

who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an

Organisation	Anika Therapeutics Inc
Headquarters	32 Wiggins Avenue, Bedford, MA, United States, 01730
Industry	Health Technology
CEO	Dr. Cheryl Renee Blanchard Ph.D.
E-voting on shares	Click here to vote

Key Management of Anika Therapeutics Inc

Name	Title
Dr. Cheryl Renee Blanchard Ph.D.	President, CEO & Director
Mr. Stephen D. Griffin	Executive VP, CFO & COO
Mr. Ian W. McLeod	VP & Chief Accounting Officer
Mr. Matthew Hall	Director of Corporate Development & Investor Relations
Mr. James Chase	Senior Vice President of International Sales & Marketing
Mr. Ben Joseph	Vice President of Commercial & Corporate Development
Ms. Lisa Funiciello	Vice President of Human Resources
Mr. David Colleran J.D.	Executive VP, General Counsel & Corporate Secretary
Mr. Mark Namaroff	Vice President of Investor Relations, ESG & Corporate Communications
Ms. Mira Leiwant	Senior Vice President of Regulatory, Quality & Clinical Affairs

FAQs

What is Anika Therapeutics Inc share price today?

Anika Therapeutics Inc share price today is $9.46 as on January 21, 2026 at 2:29 am IST at the close of the market. Anika Therapeutics Inc share today touched a day high of $9.54 and a low of $9.24.

What is the 52 week high and 52 week low for Anika Therapeutics Inc share?

Anika Therapeutics Inc share touched a 52 week high of $18.37 on February 5, 2025 and a 52 week low of $7.87 on July 31, 2025. Anika Therapeutics Inc stock price today i.e. January 21, 2026 at 2:29 am IST is closed at $9.46,which is 48.50% down from its 52 week high and 20.20% up from its 52 week low.

What is Anika Therapeutics Inc's market capitalisation today?

Anika Therapeutics Inc market capitalisation is $0.00T as on January 21, 2026 at 2:29 am IST.

How to invest in Anika Therapeutics Inc Stock (ANIK) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Anika Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anika Therapeutics Inc Shares that will get you 0.1586 shares as per Anika Therapeutics Inc share price of $9.46 per share as on January 21, 2026 at 2:29 am IST.

What is the minimum amount required to buy Anika Therapeutics Inc Stock (ANIK) from India?

Indian investors can start investing in Anika Therapeutics Inc (ANIK) shares with as little as ₹91.673 or $1 (as of January 21, 2026 at 5:50 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Anika Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on January 21, 2026 at 5:50 pm IST). Based on Anika Therapeutics Inc share’s latest price of $9.46 as on January 21, 2026 at 2:29 am IST, you will get 1.0571 shares of Anika Therapeutics Inc. Learn more about fractional shares .

What are the returns that Anika Therapeutics Inc has given to Indian investors in the last 5 years?

Anika Therapeutics Inc stock has given -75.89% share price returns and 24.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?